Enteric-coated Dosage Forms
Enteric-Coated Dosage Form is a type of oral solid dosage form designed to resist disintegration and dissolution in the acidic environment of the stomach and to release its active pharmaceutical ingredient in the more alkaline environment of the small intestine through a pH-dependent polymer coating.
432
Publications
18.6K
Citations
1.9K
Authors
635
Institutions
Publications per year
2017–2026
60
Parents
432
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
John J. McNeil, Robyn L. Woods, Mark Nelson et al. · New England Journal of Medicine · 2018 · 587 citations · Full text
1–5 of 432
1.9K
5
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 1.9K
635
University of Michigan
Ann Arbor, United States
8 h-index
26 publications
892 citations
Eli Lilly (United States)
Indianapolis, United States
8 h-index
21 publications
986 citations

University of Maryland, Baltimore
Baltimore, United States
7 h-index
18 publications
1.3K citations
Baylor College of Medicine
Houston, United States
7 h-index
22 publications
1.7K citations

Brigham and Women's Hospital
Boston, United States
6 h-index
15 publications
571 citations

Ghent University
Ghent, Belgium
5 h-index
21 publications
726 citations

University of Alberta
Edmonton, Canada
5 h-index
11 publications
229 citations
University of Florida
Gainesville, United States
5 h-index
8 publications
302 citations
1–8 of 635
25 publications · 1.1K citations
19
h-index
Repository · 38 publications · 815 citations
18
h-index
16 publications · 402 citations
13
h-index
EJPB · 13 publications · 645 citations
12
h-index
CPT · 11 publications · 640 citations
11
h-index
1–5